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Signal transduction induced by generations of second messengers from membrane phospholipids is a major
regulatory mechanism in the control of cell proliferation. Indeed, oncogenic p21ras alters the intracellular levels
of phospholipid metabolites in both mammalian cells and Xenopus oocytes. However, it is still controversial
whether this alteration it is biologically significant. We have analyzed the ras-induced signal transduction
pathway in Xenopus oocytes and have correlated its mechanism of activation with that of the three most relevant
phospholipases (PLs). After microinjection, ras-p21 induces a rapid PLD activation followed by a late PLA2
activation. By contrast, phosphatidylcholine-specific PLC was not activated under similar conditions. When
each of these PLs was studied for its ability to activate intracellular signalling kinases, all of them were found
to activate maturation-promoting factor efficiently. However, only PLD was able to activate MAP kinase and
S6 kinase II, a similar pattern to that induced by p21ras proteins. Thus, the comparison of activated enzymes
after microinjection of p21ras or PLs indicated that only PLD microinjection mimetized p21ras signalling.
Finally, inhibition of the endogenous PLD activity by neomycin substantially reduced the biological activity of
p21ras. All these results suggest that PLD activation may constitute a relevant step in ras-induced germinal
vesicle breakdown in Xenopus oocytes.
The ras family is highly conserved in evolution, being present
in organisms ranging from yeasts to humans (5). Ras proteins
activated by point mutations are found in a significant fraction
of human and carcinogen-induced animal tumors (2, 27). A
number of previous studies have demonstrated alterations in
the phospholipid metabolism induced by p21ras proteins (re-
viewed in reference 22). Ras-transformed cells show a signifi-
cant increase in the basal levels of diacylglycerol (DAG) and
phosphorylcholine (PCho) (21). We have recently shown that
these metabolites are generated by a complex pathway involv-
ing phospholipase D (PLD) activation followed by choline
kinase and phosphatidic acid (PA) hydrolase (6). Furthermore,
no significant activation of a PC-specific PLC (PC-PLC) was
observed. While a constitutively activated PC-PLD enzyme
and a twofold increase in the basal levels of PA were observed
in ras-transformed cells, very small alterations of these param-
eters were detected at late times after serum stimulation of
quiescent cells (6). Therefore, cell proliferation induced by ras
oncogenes in fibroblasts may be functionally linked to activa-
tion of a PC-PLD enzyme.
Cell proliferation in eukaryotic cells is triggered by events
initiated at the plasma membrane that control reentry into the
cell cycle. The subsequent biochemical pathways activated ac-
tually direct the process of cell division itself. Both of these
aspects of cell growth regulation can be studied in Xenopus
oocytes undergoing meiotic maturation in response to mito-
genic stimulation by hormones and mitogens (18, 31). Xenopus
oocytes are arrested at the G2/M border of the first meiotic
prophase. Several signals can induce reentry into the cell cycle,
which can be followed by the activation of different kinases,
used as biochemical markers of meiotic maturation. Several
inducers of oocyte maturation can activate a preexisting factor,
the pre-MPF (maturation-promoting factor) which is an het-
erodimer of cyclin B and the p34cdc2 protein kinase. Activation
of pre-MPF promotes reentry into the cell cycle (reviewed in
references 18, 31, and 37). As a consequence of MPF activa-
tion, there is a burst of phosphorylation of intracellular sub-
strates 30 to 60 min before the germinal vesicle breakdown
(GVBD). After the stimulation with hormones, MAP kinase
(MAP K) is activated during the M-phase transition under the
control of MPF, and it may constitute part of the kinase cas-
cade downstream of MPF (13, 15, 31). However, while p21ras
induces MAP K activation without MPF activation (8, 34),
MAP K activation still seems to be necessary for GVBD in-
duced by progesterone and p21ras (8, 20). Moreover, p42MAPK
phosphorylates and activates S6 kinase II (KII) (48), the Xe-
nopus homolog of mammalian pp90rsk (11). Thus, MPF, MAP
K, and S6 KII can be used as biochemical markers for Ras and
PL pathways in Xenopus oocytes.
Phospholipids play an important role in the control of cel-
lular responses such as secretion, platelet aggregation, macro-
phage function, and fertilization (4, 36, 40). They also play an
important role in signal transduction, since generation of sec-
ond messengers from membrane phospholipids is a major reg-
ulatory mechanism in control of cell proliferation. We have
reported that in the Xenopus laevis oocytes model, microinjec-
tion of the three most relevant types of PLs acting on mem-
brane phospholipids (PLA2, PLC, and PLD) are capable of
inducing oocyte maturation (9). This effect is mediated by the
generation of known second messengers such as lysophospho-
lipids, arachidonic acid, DAG, and PA. Furthermore, using
specific inhibitors of protein kinase C (PKC), we have identi-
fied alternative independent signalling pathways for the induc-
tion of oocyte maturation. Our results indicate that while PLC
seems to be dependent on PKC, PLA2 and PLD are com-
pletely independent of PKC function (9). In this study, we
further investigated the functional relationship between p21ras
and PLs in the X. laevis oocyte system. Our results suggest that
PLD is an important component of the ras signalling pathway
in this system, in keeping with our previous findings that ras
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and PLD lie within the same signalling pathway in the NIH
3T3 system.
MATERIALS AND METHODS
Oocyte maturation and microinjection. Stage VI oocytes were selected by
manual dissection. Series of 30 to 50 oocytes were treated for hormonal induc-
tion of maturation with 1 mg of progesterone per ml in Ringer’s buffer (100 mM
NaCl, 1.8 mM KCl, 2 mM MgCl2, 1 mM CaCl2, 4 mM NaHCO3 [pH 7.8]).
Microinjection of 25 mU of each PL or 25 ng of the p21ras protein was performed
as previously described (21). After overnight incubation at 18 to 208C in Ringer’s
buffer, oocytes were lysed for biochemical characterization or fixed in 16%
trichloroacetic acid (TCA). Visual verification of nuclear vesicle breakdown was
performed by splitting the oocytes open after fixation.
Protein purification. The v-H-ras p21 protein was purified as described pre-
viously (25). After protein induction, 7 M urea extracts were subjected to further
purification by chromatography through a Sephadex G-100 column (90 by 2.5
cm) in 7 M urea–20 mM morpholineethanesulfonic acid (MES; pH 7.0). Frac-
tions of 3 ml were collected and analyzed by sodium dodecyl sulfate-polyacryl-
amide gel electrophoresis (SDS-PAGE) to estimate purity and by a GTP-binding
assay to determine the activity of p21ras. Fractions containing up to 95% purified
p21ras were pooled and dialyzed against 20 mM MES (pH 7.0), and the concen-
trations were estimated by the Bradford assay system (Bio-Rad).
PLs were obtained from Sigma. Their respective origins are as follows: bee
venom for PLA2, Bacillus cereus type III for PLC, and peanut type II for PLD.
Analysis of PA and phosphatidylbutanol production. Oocytes were incubated
for 8 h in Ringer’s buffer containing 0.5 mCi of 32P per ml and rinsed twice to
remove unincorporated isotope. Following microinjection of 50 nl of a solution
containing either 1 mg bovine serum albumin (BSA) per ml, 1 mg of p21ras per
ml, or 0.5 U of PC-PLD per ml, the reactions were stopped at the indicated times
in an ethanol bath kept at 2708C. PA and phosphatidylbutanol were extracted
with 160 ml of water and 0.6 ml of chloroform-methanol (1:1, vol/vol). The
organic phase was lyophilized under a nitrogen stream, resuspended in 100 ml of
chloroform and resolved on thin-layer chromatography plates with the upper
phase (100 ml) consisting of a mixture of ethyl acetate, trimethyl pentane, acetic
acid, and H2O (90:50:20:100, by volume), to which 1 ml of acetic acid was added.
The thin-layer chromatography plates were exposed to an X ray film, and the
radioactive spots were quantified by scratching and scintillation counting.
MPF assays.MPF assays were carried out with total extracts from series of 10
oocytes treated with progesterone or given microinjections of p21ras protein or
PLs. After incubation for 18 to 20 h, oocytes were homogenized in BLO buffer
containing 20 mM N-2-hydroxyethylpiperazine-N9-2-ethanesulfonic acid (HEPES;
pH 7.0), 10 mM b-glycerophosphate, 5 mM ethylene glycol-bis(b-aminoethyl
ether)-N,N,N9,N9-tetraacetic acid EGTA, 5 mM MgCl2, 50 mM NaF, 2 mM
dithiothreitol, 10 mg of leupeptin per ml, 25 mg of aprotinin per ml, and 100 mM
phenylmethylsulfonyl fluoride. Following centrifugation at 13,0003 g for 15 min,
extracts were assayed for 15 min at 308C in a final reaction volume of 50 ml
containing 20 mM HEPES (pH 7.0), 5 mM b-mercaptoethanol, 10 mM MgCl2,
100 mM [a-32P]ATP (2 to 5 dpm/fmol), 0.2 mg of PKA inhibitor, and 1 mg of type
III S calf thymus histone (Sigma) per ml. Reactions were stopped by addition of
PAGE sample buffer and boiling for 5 min. The samples were subjected to
PAGE (15% polyacrylamide), dried, and exposed at 2708C. The band corre-
sponding to H1 was excised from the gel and quantitated by a scintillation
counter.
S6 KII assay. To determine S6 KII activity in total extracts, series of 20 oocytes
were homogenized in BLO buffer in a final volume of 200 ml. Extracts were
centrifuged in a Biofuge A (Heraeus Sepatech) at 13,000 rpm for 15 min, and 30
ml of supernatant was assayed with pp90rsk substrate peptide. The reaction
mixture, in a final volume of 50 ml, contained 250 mM rsk substrate peptide
(UBI), 50 mM glycerophosphate (pH 7.3), 7 mM NaF, 0.3 mM EDTA, 150 mM
MgCl2, 2 mM dithiothreitol, 50 mM [a-32P]ATP (3,000 Ci/mmol; Amersham),
and 7 mM PKA inhibitor peptide (Sigma). The assay mixtures were incubated at
308C for 20 min, and the reactions were stopped with ice-cold TCA to a final
concentration of 16% TCA. Samples were maintained for 15 min at 48C and
centrifuged in a Biofuge A (Heraeus Sepatech) at 13,000 rpm for 15 min. The
supernatants were spotted onto Whatman p81 phosphocellulose paper filters and
washed extensively with 1% orthophosphoric acid and once with 95% ethanol.
The radioactivity retained on the filters was quantified in a scintillation counter.
RESULTS
Activation of PLD by microinjection of p21ras. We have
recently shown that in ras-transformed fibroblasts there is a
sustained activation of PLD activity, resulting in constitutive
elevation of PA levels (6). This could be generated as a con-
sequence of direct or indirect activation of PLD mediated by
Ras protein. To investigate whether p21ras induces the early
activation of PLD, we analyzed PA production after microin-
jection of p21ras into X. laevis oocytes. Oocytes were labeled
with 0.5 mCi of 32Pi per ml at room temperature for 18 h,
washed extensively, and given microinjections of 25 mU of
PLD, 50 ng of the purified p21ras protein, or equivalent
amounts of BSA. PA levels were analyzed 30 min after injec-
tion. As shown in Fig. 1A, microinjection of either p21ras or
PLD induced a rapid increase in the level of PA.
There are alternative mechanisms for the generation of PA,
such as direct activation of a PKC-independent PLD, activa-
tion of a PLD by a PKC-dependent pathway, or activation of a
DAG kinase (DGK). Therefore, the levels of PA were ana-
lyzed in oocytes pretreated with the PKC inhibitor bisindolyl-
maleimide or the DGK inhibitor R59022. Ras- and PLD-in-
duced production of PA was not affected by the PKC inhibitor
(Fig. 1A), suggesting that p21ras can induce PA production in
FIG. 1. Activation of PLD by p21ras. (A) Oocytes were prepared as described in Materials and Methods. After 18 h of incubation with 0.5 mCi of 32Pi per ml at
room temperature, oocytes were washed and incubated for 2 h in the presence of 10 mM GF109203X (1), 100 mM (final concentration) R59022 (microinjected) (o),
or buffer alone (n). Oocytes were further given microinjections of 50 ng of purified p21ras or BSA or 25 mU of PLD. After 1 h of incubation, PA was analyzed as
described in Materials and Methods. (B) Oocytes were given microinjections of 100 mMR59022 (o) or buffer alone (n). After 2 h of incubation, the oocytes were given
microinjections of 25 nCi of [a-32P]ATP per oocyte and 50 ng of BSA or p21ras per oocyte or 25 nl of purified DGK. After 30 min of incubation at room temperature,
the oocytes were processed for PA production as described in Materials and Methods. (C) Oocytes were incubated for 18 h with 0.5 mCi of32Pi per ml at room temperature,
washed, given microinjections of 50 ng of purified p21ras or BSA, and incubated for 1 h in Ringer’s buffer containing 0.5% n-butanol. The phosphatidylbutanol produced was
analyzed as described in Materials and Methods. Data represent the average of triplicate samples (10 oocytes per sample)6 standard deviation SD.
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a PKC-independent form. Moreover, the PA production in-
duced by p21ras is not affected by R59022, suggesting that PA
was generated by a mechanism involving PLD activation rather
than by activation of DGK.
To further confirm this conclusion, we have analyzed PA
production under conditions where it can proceed only from
DGK activity. Oocytes were given microinjections of 100 mM
R59022 or buffer alone. After 2 h of incubation, oocytes were
given microinjections of 25 nCi of [g-32P]ATP per oocyte and
50 ng of BSA or p21ras per oocyte, or 25 nl of purified DGK.
After 30 min of incubation at room temperature, the oocytes
were processed for PA production as described in Materials
and Methods. Under these conditions, the observed labeled
PA would originate from DGK activity since insufficient radio-
activity is incorporated into phospholipids (data not shown).
As shown in Fig. 1B, microinjection of DGK induced a 33-fold
increase in the PA levels, and this increase was inhibited by
R59022, an indication of its generation through the DGK en-
zyme. However, under the same conditions, p21ras was unable
to induce PA generation, indicating that ras-induced PA orig-
inated directly from phospholipid hydrolysis by PLD activa-
tion. These results were confirmed when we analyzed the ras-
induced PLD activity directly by its specific transphos-
phatidylating activity. Oocytes were labeled with 0.5 mCi of
32Pi per ml at room temperature for 18 h, washed extensively,
and then given microinjections of 50 ng of purified p21ras
protein or BSA. Oocytes were further incubated for 1 h in the
presence or absence of 0.5% n-butanol, and the [32P]phos-
phatidylbutanol levels were analyzed. Microinjection of p21ras
induced a rapid increase in the transphosphatidylating activity
(Fig. 1C), confirming that the ras-induced PA production is
due to activation of a PLD enzyme.
Inhibition of p21ras-induced GVBD.Microinjection of p21ras
protein into X. laevis oocytes induces the production of DAG
(21, 23). It has been suggested that this DAG production is a
consequence of PC-PLC activation (10, 14, 30) and that this
activation is necessary for ras-induced GVBD. We have previ-
ously demonstrated that microinjection of a B. cereus PLC is
able to induce GVBD and this effect is dependent on PKC,
since PKC inhibitors efficiently block PLC-, DAG-, and tetra-
decanoyl phorbol acetate-induced GVBD (9). Moreover,
GVBD induced by PLD and PLA2 seems to be independent of
the PKC pathway. To study whether p21ras requires a func-
tional PC-PLC enzyme, we have microinjected p21ras in the
presence of different concentrations of bisindolylmaleimide
(GF109203X). As shown in Fig. 2A, this PKC inhibitor effi-
ciently blocks tetradecanoyl phorbol acetate-induced GVBD
but does not interfere with the GVBD induced by progester-
one or p21ras. This result indicate that ras-induced GVBD is
independent of the PLC-PKC pathway and that the ras-in-
duced DAG production is most probably not necessary for
oocyte maturation.
In NIH 3T3 cells, transformation by activated p21ras induces
PLD activation, with a significant increase in the PA levels (6).
Thus, we have analyzed whether PLD activation is necessary
for the GVBD induced by Ras proteins. Neomycin has been
reported to inhibit the PC-PLD activity with a 50% inhibitory
concentration of 65 mM in vitro, and it is able to block the
PC-PLD activity in vivo at concentrations near to 1 mM (29).
Therefore, we investigated whether PLD activity was necessary
for ras function in this system. Neomycin was able to block the
p21ras-induced GVBD in a dose-dependent manner (Fig. 2B)
and with comparable results to those shown by others (38).
This effect was parallel with a drastic reduction in ras-induced
PLD activation (data not shown). Thus, the ras-induced
GVBD seems to be independent of PC-PLC activity but de-
pendent on PC-PLD activity. However, the lack of specificity
of this drug made it necessary to explore other approaches to
the problem. Therefore, we analyzed the PLD-induced bio-
chemical pathway in the X. laevis oocytes and compared it with
that of p21ras and the other PLs (PLC and PLA2).
MPF activity associated with PL-induced GVBD. A number
of phospholipid metabolites have been proven capable of trig-
gering mitogenic signals in eukaryotic cells. Microinjection of
PLA2, PLC, or PLD into X. laevis oocytes induces the G2-to-M
phase transition through the generation of second messengers
generated from phospholipid breakdown, since DAGs, PA,
arachidonic acid, lyso-PC, and lysophosphatidylinositol each
induce the same effects (9). This effect is comparable to the
biological activity of progesterone, phorbol esters, or p21ras.
Mitogenic stimulation of X. laevis oocytes can be monitored
by measuring posttranslational modification of the key en-
zymes involved in the process. Quiescent stage VI oocytes
contain inactive MPF. Upon stimulation with progesterone or
the oncogenic p21ras protein, the MPF complex is activated.
When we measured the p34cdc2 kinase activity in extracts of
PL-injected oocytes, we observed a similar H1 kinase activity in
all of them when compared with that observed in extracts from
oocytes treated with progesterone or given microinjections of
p21ras proteins (results not shown).
A more detailed analysis of the time course of MPF activa-
FIG. 2. Effects of the PKC inhibitor GF109203X and neomycin in Ras-
induced GVBD. Oocytes were prepared as described in Materials and Methods.
p21ras (25 ng) (F) was microinjected per oocyte in a volume of 25 nl in 20 mM
MES buffer. Treatments were carried out with 10 mg of progesterone per ml (E)
or 100 nM TPA (n). Oocytes were incubated with different concentrations of the
indicated inhibitor. GVBD was analyzed 18 h after microinjection or treatment
by fixing in 10% TCA.
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tion shows that progesterone induced the H1 phosphorylation
at least 2 h before the GVBD took place, correlating with the
results reported by other groups (reviewed in reference 31).
However, p21ras induced MPF activity only after a significant
level of GVBD was reached, indicating that ras-induced MPF
activation does not precede GVBD. When MPF activation was
analyzed after microinjection of PLs (Fig. 3) and compared
with the GVBD, we observed that PLA2 induced a rapid
GVBD (almost 100% at 4 h). However, PLD and PLC induced
GVBD more slowly. Activation of MPF by PLA2 was rapid but
did not precede the GVBD, since it was maximal at 6 h, 2 h
after complete GVBD induction was observed. PLD also
showed a late MPF activation but only after GVBD was ob-
served. Finally, PLC showed a partial activation of MPF that
preceded GVBD. Thus, a comparison between p21ras- and
PL-induced activation of MPF showed that ras and PLD had
similar kinetics.
MAP K is activated by PLD but not by PLC or PLA2.
Mammalian MAP K is a serine/threonine kinase whose acti-
vation and phosphorylation on Tyr and Thr residues are rap-
idly induced by a variety of mitogens (16, 17, 26, 43–45). This
kinase is considered to have a critical role in a network of
protein kinases in mitogenic signal transduction (see refer-
ences 32, 35, and 39 for reviews). Xenopus p42MAPK is also a
Ser/Thr kinase closely related to the mammalian MAP K. It is
phosphorylated on Tyr and Thr residues, a mechanism for its
activation which takes place during entry into the M phase in
the cell cycle of the Xenopus oocyte.
We have investigated the activation of MAP K by microin-
jection of PLs. As shown in Fig. 4A, PLD was able to induce
MAP K activation, as indicated by a net shift in electrophoretic
mobility observed on SDS-PAGE. By contrast, neither PLA2
nor PLC was capable of activating this enzyme. A similar effect
on MAP K activation was also observed after microinjection of
1-stearoyl-2-arachidonoyl-PA, strengthening our conclusion
that PLD induces activation of MAP K.
To further demonstrate the activation of MAP K after PLD
microinjection, an alternative assay was performed as shown in
Fig. 4B. After microinjection of either Ras, PLD, or BSA into
oocytes or after treatment of oocytes with progesterone, the
oocytes were incubated for 9 h in Ringer’s buffer. Then the
oocytes were lyzed in BLO buffer and samples were immuno-
precipitated with an anti-phosphotyrosine antibody. The re-
sulting immunoprecipitates were then resolved by PAGE (10%
polyacrylamide), transferred to nitrocellulose, and Western
immunoblotted with an anti-MAP K antibody. Either proges-
terone, Ras, or PLD treatment was sufficient to induce tyrosine
phosphorylation of MAP K. These results suggest that the
three PLs follow different pathways for induction of GVBD
and that only PLD activates p42MAPK like progesterone or
p21ras does.
S6 KII activation is induced by PLD but not by PLC or
PLA2. Phosphorylation of the 40S ribosomal protein S6 is com-
mon to all known oocyte maturation inducers. This process is
one of the last known events in the kinase pathway that leads
to reentry into mitosis in oocytes (31). In X. laevis oocytes, the
S6 protein phosphorylation is mostly mediated by S6 KII, a
member of the pp90rsk family (11). We have analyzed the time
course of S6 KII activation induced by microinjection of PLs
with a specific peptide substrate for this family. As expected
FIG. 3. Time course of p21ras- and PL-induced activation of MPF. (A) Time course of GVBD induced by progesterone (E) or p21ras (F). (B) Time course of GVBD
induced by PLA2 (E), PLD (F), PLC (), or BSA (h). (C) Time course of MPF activation induced by progesterone (E) or p21ras (F). (D) Time course of MPF
activation induced by PLA2 (E), PLD (F), PLC (), or BSA (h). Oocytes were treated with 10 mg of progesterone per ml or given microinjections of 25 mU of PLA2,
PLC, or PLD per oocyte or 25 ng of v-H-ras of p21 protein (Ras) or BSA per oocyte (C). At the indicated times, oocytes were put in ice and processed for the MPF
assay (C and D) or fixed in 16% TCA for GVBD analysis (A and B). The MPF assay was performed as described in Materials and Methods with extracts from treated
or microinjected oocytes as indicated. The phosphorylated band corresponding to the H1 protein was cut and counted.
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from the results of MAP K activation, PLD was able to induce
activation of this kinase with a similar kinetics to that of Ras or
progesterone (Fig. 5). By contrast, neither PLC nor PLA2 was
able to significantly activate S6 KII. Finally, PA alone was also
able to induce S6 KII activation at 16 h after injection, with a
similar efficiency to that of PLD, Ras, or progesterone, sug-
gesting that PLD-mediated activation of S6 KII is mediated by
the generation of PA.
Since cycloheximide (CHX) was able to block MPF-depen-
dent signals (8), we used this inhibitor to study whether S6 KII
activation in progesterone-, PLD- and ras-induced oocytes fol-
lows similar pathways. As shown in Fig. 6A, when oocytes were
treated with CHX and then stimulated with progesterone, no
activation of the S6 KII enzyme could be detected, indicating
that S6 KII activation requires protein synthesis. In contrast,
when the oocytes were given microinjections of the p21ras pro-
tein or PLD, the S6 KII enzymatic activity could be detected at
a similar rate to that in control CHX-untreated oocytes. More-
over, microinjection of 200 ng of PA per oocyte resulted in a
similar pattern of phosphorylation to that observed by micro-
injection of p21ras or PLD (data not shown). These results
indicate that S6 KII activation induced by ras, PLD, or PA
follows routes that do not require protein synthesis.
2-Aminopurine (2-AP) is a purine analog that has been
described as a rather selective inhibitor of protein kinases
activated by certain growth factors (49, 50). In particular, 2-AP
blocks ras-induced activation of p44ERK1 in PC12 cells (42) and
in X. laevis oocytes (8). Therefore, we studied the effects of
2-AP treatment on the intracellular signals generated by pro-
gesterone and PLs and compared them with those induced by
FIG. 4. Activation of p42MAPK by PLs and PA. (A) Activation of p42MAPK
was measured by Western blot as the mobility shift of the kinase after electro-
phoresis in polyacrylamide gels. Total extracts of control (BSA), PLA2-, PLC-,
PA-, or PLD-microinjected oocytes or oocytes treated with progesterone were
run on PAGE (10% polyacrylamide), transferred to nitrocellulose, and incu-
bated in the presence of an a-MAP K polyclonal antibody followed by a bioti-
nylated anti-rabbit antibody and streptavidin-peroxidase conjugated protein. (B)
Oocytes were given microinjections of p21ras, PLD, or BSA or treated with
progesterone (Pr) and incubated for 9 h in Ringer’s buffer. After this time,
oocytes were lyzed in BLO buffer and immunoprecipitated with an anti-phos-
photyrosine (a-PTyr) antibody as follows. Oocyte extracts were incubated for 8
h at 48C with the anti-phosphotyrosine antibody and then for 30 min with protein
A-Sepharose beads, linked to a goat anti-mouse antibody. Immunoprecipitates
were washed three times in BLO buffer, and the resulting pellets were resolved
by PAGE (10% polyacrylamide). Proteins were transferred to nitrocellulose and
immunoblotted with the anti-MAP K (a-MAPK) polyclonal antibody. Where
indicated, extracts were inhibited with phosphotyrosine at the time of incubation
with the anti-phosphotyrosine antibody. Blots were developed by the ECL system
as recommended by the manufacturer (Amersham).
FIG. 5. Activation of S6 KII by PLs. Activation of the S6 KII was determined
as described in Materials and Methods by phosphorylation of the rsk substrate
peptide. Total-oocyte extracts were analyzed from unstimulated oocytes (zero
time point), oocytes treated with 10 mg of progesterone per ml (h) or given
microinjections of 25 mU of PLA2 (n), PLC (), or PLD (F) per oocyte or 25
ng of v-H-ras-p21 protein per oocyte (E), or 300 ng of PA per oocyte. Data
shown for PA microinjection were determined at 16 h of microinjection.
FIG. 6. Effect of CHX or 2-AP treatment on the activation of S6 KII. Phos-
phorylation of the rsk substrate peptide in total-oocyte extracts was performed as
described in Materials and Methods. Extracts were obtained from unstimulated
oocytes (C), oocytes treated with 10 mg of progesterone (Pr) per ml, or oocytes
given microinjections of 25 mU of PLD per oocyte or 25 ng of v-H-ras-p21
protein (Ras) per oocyte. Solid bars indicate untreated oocytes; striped bars
indicate CHX-treated (A) or 2-AP-treated (B) oocytes. Error bars indicate the
standard error of duplicate samples.
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p21ras proteins. When oocytes were treated with 2-AP and then
stimulated with progesterone, a complete inhibition of S6 KII
activity was observed (Fig. 6B), indicating that S6 KII activa-
tion by progesterone depends on MAP K activity. Similar re-
sults were also observed in PLD- and ras-microinjected oo-
cytes, indicating that PLD- and ras-induced activation of S6
KII may also be mediated by activation of the MAP K. Finally,
when we analyzed the effect of 2-AP treatment on PA-induced
S6 KII activation, we found that it was also blocked (data not
shown), supporting the functional connection of p21ras, PLD,
and PA in this system.
Protein synthesis and MAP K requirement for PL-induced
GVBD. GVBD induced by the three PLs analyzed is indepen-
dent of CHX (Table 1), as has been previously shown for ras
(1). By contrast, GVBD induced by progesterone is dependent
on protein synthesis. Inhibition of GVBD by 2-AP seems to be
related to the requirement of MAP K, since only inducers that
activate MAP K are blocked by this drug: progesterone, PLD,
and p21ras (Table 1). In contrast, PLA2 and PLC can bypass the
2-AP effect, indicating that they follow a different pathway
from that of MAP K activation. The fact that PLA2 and PLC
can bypass the drug effect indicates that inhibition of the bio-
logical activity of PLD, ras, and progesterone by 2-AP treat-
ment is not a result of a nonspecific effect or toxicity.
PL microinjection can induce GVBD through generation of
their respective known metabolites (9). Therefore, we analyzed
whether active lipid metabolites were sensitive to CHX and
2-AP inhibition. As shown in Table 2, none of the metabolites
generated by PLA2, PLC, or PLD were significantly sensitive to
CHX. By contrast, PA, the only biologically active metabolite
in X. laevis oocytes generated by PLD, was significantly sensi-
tive to 2-AP treatment, as shown for PLD microinjection.
DISCUSSION
PLs are key enzymes responsible for the generation of im-
portant intracellular lipid metabolites and second messengers
involved in the regulation of the most relevant signaling pro-
cesses in a large variety of cells (3, 12, 36). While the PL-
induced processes in somatic cells have been extensively stud-
ied, much less information is available about the regulation of
germinal cell cycles by PLs. We provide evidence that PLA2,
PLC, and PLD are also powerful biological effectors in the
Xenopus oocyte system and activate intracellular signalling
pathways.
PLA2, PLC, and PLD were able to activate p34
cdc2 kinase as
did p21ras. However, the time course of p34cdc2 kinase activation
showed clear differences among PLs. While PLC and PLA2
showed a rapid activation, PLD, like p21ras, showed a similar
delayed H1 kinase activation. Moreover, none of the PLs stud-
ied were inhibited by CHX in their biological activity, suggest-
ing that, like p21ras proteins, PLs do not need protein synthesis
for oocyte maturation. p42MAPK is activated by progesterone
and p21ras, and this activation is necessary for oocyte matura-
tion (8, 20). These results are in agreement with previous
observations indicating that oocyte maturation requires MPF
in progesterone- but not ras-induced GVBD (34). PLD, like
progesterone and ras, activates p42MAPK. In contrast, PLC and
PLA2 do not, indicating that ras and PLD follow a different
pathway from PLC and PLA2. Thus, both MPF and MAP K
seems to be sufficient elements to distinguish among signalling
routes in oocytes, clearly indicating that ras is not related to
PLC.
Cytosolic PLA2 is phosphorylated and activated by MAP K
(28). This suggests that PLA2 is located downstream of MAP K
in the pathway and can explain the lack of detected activation
of MAP K by PLA2 injection. Indeed, when oocytes were
treated with 2-AP, a MAP K inhibitor, the activation of PLA2
by p21ras or PLD microinjection was abolished, indicating that
PLA2 is located downstream of MAP K activation (7). Finally,
since PLC was unable to activate p42MAPK and PLA2 in oo-
cytes, it must be located within an alternative pathway to MAP
K activation for the induction of GVBD in Xenopus oocytes.
MAP K phosphorylates and activates S6 KII (48). There-
fore, inducers that activate MAP K should also activate S6 KII.
Progesterone and oncogenic p21ras activate S6 KII through
activation of MAP K (8). We show that PLD, which activates
p42MAPK, also activates S6 KII. By contrast, in X. laevis oo-
cytes, PLA2 and PLC failed to activate pp90
rsk, another indi-
cation that p21ras and PLD follow different pathways from PLC
in this system.
We have also analyzed the dependency of S6 KII activation
on protein synthesis and MAP K activity. Oocytes stimulated
with progesterone showed S6 KII activation which was sensi-
tive to CHX treatment, indicating that its activation is depen-
dent on protein synthesis. In contrast, PLD- or ras-induced
oocytes showed S6 KII activation and GVBD independent of
protein synthesis. These results are consistent with the previ-
ous studies suggesting that although progesterone needs pro-
tein synthesis for p42MAPK activation, ras-induced p42MAPK
TABLE 1. Effect of CHX or 2-AP treatment on Xenopus
oocyte maturationa
Oocyte
stimulation
GVBDb after treatment with:
CHX 2-AP
Progesterone 15 6 3 8 6 5
PLA2 111 6 12 100 6 10
PLC 91 6 10 70 6 20
PLD 100 6 2 10 6 5
p21ras 100 6 5 12 6 4
a Oocytes were prepared as described in Materials and Methods. A 25-mU
portion of each PL was microinjected per oocyte in a volume of 25 nl in MES
buffer. BSA (25 ng) as negative control or p21ras (50 ng) as a positive control
were microinjected per oocyte in a volume of 25 nl in 20 mM MES buffer.
Treatments were carried out with 10 mg of progesterone per ml. Induction of
GVBD was analyzed 18 h after microinjection or treatment by fixing in 10%
TCA.
b Data represent the mean and standard deviation of two independent exper-
iments and are shown as a percentage of the value for untreated oocytes.
TABLE 2. Effect of CHX or 2-AP treatment on the induction of
Xenopus oocyte maturation by PLsa
Oocyte stimulationb
GVBDc after treatment with:
CHX 2-AP
PLA2 metabolites
Lyso-PI 93 6 7 87 6 14
Lyso-PC 103 6 2 65 6 5
AA 89 6 8 111 6 8
PLC metabolite
S-A-Gly 100 6 10 117 6 12
PLD metabolite
PA 99 6 1 36 6 4
a Oocytes were prepared as described in Materials and Methods. Each me-
tabolite (200 ng) was microinjected per oocyte in a volume of 25 nl in MES
buffer.
b Abbreviations: Lyso-PC, lysophosphatidylcholine; Lyso-PI, lysophosphatidy-
linositol; S-A-Gly, stearoyl-arachidonoyl-glycerol; AA, arachidonic acid.
c GVBD was analyzed 18 h after microinjection or treatment by fixing in 10%
TCA. Data represent the mean and standard deviation of two independent
experiments and are shown as a percentage of the value for untreated oocytes.
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activation is independent of protein synthesis (8, 46). We re-
port that PLD is also insensitive to CHX for S6 KII activation,
again a good correlation to the function of Ras proteins.
2-AP, a reported protein kinase inhibitor, was able to block
the S6 KII activation by ras and progesterone. We have ob-
served that 2-AP blocks ras- and progesterone-induced activa-
tion of MAP K in oocytes (8), suggesting that MAP K is
necessary for the induction of S6 KII activation. Our results
indicate that PLD-induced activation of S6 KII is also sensitive
to 2-AP.
It has been suggested that p21ras is functionally dependent
on a PC-PLC activity (10, 14, 30). However, analysis of the
biochemical pathways of cell cycle-dependent kinases followed
by the three more important PLs compared with the ras pathway
indicates that this hypothesis does not appear to be correct. p21ras
activates p42MAPK and S6 KII. In contrast, a nonspecific PLC
that is able to hydrolyze both PC and phosphatidylinositol (9)
does not activate p42MAPK and S6 KII. PLD, as well as p21ras,
activates p42MAPK and S6 KII, and its ability to induce GVBD is
independent of protein synthesis. We also show in this study
that PLD- but not PLA2- or PLC-induced GVBD was sensitive
to 2-AP treatment. Moreover, the PKC inhibitor bisindolylma-
leimide inhibits the PLC- and DAG-induced GVBD (7) but
not the ras-induced GVBD (Fig. 2A). Therefore, our results
suggest that p21ras does not activate PLC but may be function-
ally related to PLD, since both proteins show a similar pattern
of signalling during GVBD induction.
When we analyzed the functional relationship between these
two proteins, we found that oncogenic p21ras was able to in-
duce the PLD activity with a net PA production, which would
be sufficient to induce GVBD (9). Moreover, treatment with
propanolol, a well-known inhibitor of the PA-phosphohydro-
lase, inhibits DAG production but does not alter ras-induced
GVBD (results not shown), indicating that this biological effect
is not mediated by DAG. Also, we have recently shown that in
ras-transformed NIH 3T3 fibroblasts there is a sustained acti-
vation of PLD (6), further supporting the hypothesis of a
functional link between p21ras and PLD.
It has been shown that src-induced transformation may be
connected to activation of PLD in murine fibroblasts through
a GTP-binding protein (19, 47). PDGFmay be also functioning
through activation of PLD (41) rather than activation of a
PC-PLC. Since microinjection of Y13-259, a neutralizing anti-
body against p21ras proteins, efficiently blocks both PDGF and
src function (33), it is reasonable to postulate that all these
mitogenic signals may have a common mechanism that implies
the generation of PA. However, the exact implication of this
metabolite in the ras-induced pathways in different systems is
still unknown; further research is required to elucidate this.
A clear connection between insulin and ras has been re-
ported for both mammalian cells and Xenopus oocytes (re-
viewed in reference 22). We have also observed that insulin-
induced GVBD in oocytes is associated with a rapid
production of PA, similar to that observed after p21ras micro-
injection (data not shown). These results suggest the putative
involvement of p21ras as the coupling system of insulin receptor
and PLD; this deserves further investigation.
In summary, in X. laevis oocytes, microinjection of purified
oncogenic p21ras protein induces activation of PLD, and inhi-
bition of this enzyme by neomycin blocks the ras-induced
GVBD. Moreover, the pathway activated by p21ras that leads
to GVBD correlates with the PLD-induced pathway. Thus,
activation of PLD by p21ras proteins may be an essential step in
the pathway that leads to DNA synthesis in X. laevis oocytes, as
we have previously demonstrated in the NIH 3T3 cell system.
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